263 related articles for article (PubMed ID: 30138145)
1. POEMS syndrome.
Keddie S; Lunn MP
Curr Opin Neurol; 2018 Oct; 31(5):551-558. PubMed ID: 30138145
[TBL] [Abstract][Full Text] [Related]
2. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
3. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
[TBL] [Abstract][Full Text] [Related]
4. POEMS syndrome: update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2015 Oct; 90(10):951-62. PubMed ID: 26331353
[TBL] [Abstract][Full Text] [Related]
5. The Peripheral Neuropathies of POEMS Syndrome and Castleman Disease.
Mauermann ML
Hematol Oncol Clin North Am; 2018 Feb; 32(1):153-163. PubMed ID: 29157616
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
7. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2014 Feb; 89(2):214-23. PubMed ID: 24532337
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
9. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2011 Jul; 86(7):591-601. PubMed ID: 21681783
[TBL] [Abstract][Full Text] [Related]
10. POEMS syndrome: update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2012 Aug; 87(8):804-14. PubMed ID: 22806697
[TBL] [Abstract][Full Text] [Related]
11. POEMS syndrome: clinical update.
Brown R; Ginsberg L
J Neurol; 2019 Jan; 266(1):268-277. PubMed ID: 30498913
[TBL] [Abstract][Full Text] [Related]
12. An update on the diagnosis and management of the polyneuropathy of POEMS syndrome.
Cerri F; Falzone YM; Riva N; Quattrini A
J Neurol; 2019 Jan; 266(1):258-267. PubMed ID: 30264176
[TBL] [Abstract][Full Text] [Related]
13. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
[TBL] [Abstract][Full Text] [Related]
14. [POEMS-syndrome].
Arkhipov IE; Vergunova IY; Malkova NA; Korobko DS
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7. Vyp. 2):15-21. PubMed ID: 37560829
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
16. Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs.
Marsh ES; Keddie S; Terris-Prestholt F; D'Sa S; Lunn MP
J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):172-176. PubMed ID: 33106368
[TBL] [Abstract][Full Text] [Related]
17. POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.
Dispenzieri A
Am J Hematol; 2017 Aug; 92(8):814-829. PubMed ID: 28699668
[TBL] [Abstract][Full Text] [Related]
18. [POEMS syndrome: a review of the literature].
Méndez-Herrera CR; Cordoví-Rodríguez D
Rev Neurol; 2011 Jul; 53(1):44-50. PubMed ID: 21678324
[TBL] [Abstract][Full Text] [Related]
19. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
20. POEMS syndrome: the matter-of-fact approach.
Scarlato M; Previtali SC
Curr Opin Neurol; 2011 Oct; 24(5):491-6. PubMed ID: 21677582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
